Objective To investigate the clinical effect and application value of rosuvastatin versus atorvastatin in the treatment of acute coronary syndrome.Methods The patients with acute coronary syndrome treated at our hospital were divided into two a control group and an observation group using random number table method.The control group were treated with atorvastatin and the observation group rosuvastatin.The treatment effects of both groups were recorded.Results After the treatment,the levels of total cholesterol,triglyceride,low density lipoprotein,high-sensitivity C-reactive protein,and IL-6 were (4.02 ± 0.37) mmol/L,(1.85 ± 0.13) mmol/ L,(2.46 ± 0.28) mmol/L,(3.11±0.52) mg/L,and (13.44 ± 235) μg/ml in the observation group,which were much better than those in the control group (P ＜ 0.05).Conclusions Rosuvastatin can effectively reduce the blood lipid and inflammatory levels in patients with acute coronary syndrome.%目的 探讨瑞舒伐他汀同阿托伐他汀治疗急性冠脉综合征的临床疗效及应用价值.方法 将本院治疗的急性冠脉综合征患者随机数字表法分为两组,对照组给予阿托伐他汀治疗,观察组采用瑞舒伐他汀治疗,记录两组效果.结果 观察组治疗后总胆固醇为(4.02±0.37) mmol/L,甘油三酯为(1.85±0.13)mmol/L,低密度脂蛋白为(2.46±0.28) mmol/L,显著优于对照组(P＜ 0.05).观察组治疗后高敏C反应蛋白为(3.11±0.52) mg/L,IL-6为(13.44±2.35) μg/ml,与对照组比较差异有统计学意义(P＜0.05).结论 瑞舒伐他汀治疗急性冠脉综合征可以有效降低患者血脂浓度,减轻患者体内血管炎症因子作用程度.
展开▼
